AlzProtect alzprotect.com


Public lists: Pharma Startups (4732)

AlzProtect is developing anti-Alzheimer drugs acting through an original mechanism of action and discovered in a collaborative work of several years at INSERM and the University of Lille 2. Its main lead molecule, AZP2006, intended for the treatment of Alzheimer disease (AD) and possibly Frontotemporal Dementia (FTD) has achieved proof of concept in animals and will enter clinical Phase 1 in early 2014. Additional backup and biomarkers to guide clinical trials are in development. The objective o...Show all

AlzProtect is developing anti-Alzheimer drugs acting through an original mechanism of action and discovered in a collaborative work of several years at INSERM and the University of Lille 2. Its main lead molecule, AZP2006, intended for the treatment ...Show all

Company (Alive / Active)

Phone:

Fax:

Parc Eurasanté
70 rue du Dr. Yersin
Loos, 59120
France

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
AlzProtect $19.9M Jan 22, 2018
See all 18 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related AlzProtect Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 8 investors
There is no Board of Directors data available for this company. Please select another tab.

Competitors

Company Status Description Investors
See all 18 competitors